Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Small cell lung cancer | R-HSA-5619066 | map05222 | alexidine | 2090 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | aminophylline | 9433 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | aminophylline | 9433 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | aminophylline | 9433 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | aminophylline | 9433 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | aminophylline | 9433 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | aminophylline | 9433 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | aminophylline | 9433 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | esculetin | 3503 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | esculetin | 3503 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | esculetin | 3503 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | esculetin | 3503 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | STOCK1N-35696 | None | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | STOCK1N-35696 | None | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | STOCK1N-35696 | None | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | STOCK1N-35696 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | STOCK1N-35696 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Gly-His-Lys | 73587 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | Gly-His-Lys | 73587 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | Gly-His-Lys | 73587 | drug-path |